On-Demand Webinar

Clinical Operations Excellence: How Cook Research is Taking Advantage of Digital

Register Now

Modernizing clinical trial operations is a top priority among life science companies, as indicated by the 98% of respondents in the Veeva 2020 Clinical Operations Survey.

While this is an industry-wide priority, progress can be hindered by legacy systems and processes that slow study execution, limit visibility, and make data sharing and collaboration difficult.

Cook Research (a Cook Medical company) is among those leading the way to a unified approach. Cook Research took the steps to modernize its clinical operations by implementing new solutions including eTMF,  CTMS, and Payments in order to improve compliance, streamline operations, seamlessly manage trials, and improve overall study performance.

Even when COVID-19 presented challenges, Cook Research was able to keep existing studies on track and speed new studies to gain a competitive edge.

Watch this session on-demand to hear Jennifer Kerr, President at Cook Research, share:

  • Industry trends to improve clinical study performance
  • Factors that accelerate implementation
  • Achieving visibility, oversight, and collaboration
  • Quantifying value of unified clinical operations

Jennifer Kerr

President

Cook Research

Jennifer Kerr is the President of Cook Research Incorporated (a Cook Medical Company), in the Purdue Research Park, West Lafayette, Indiana. Jennifer’s role includes executive oversight of product development, testing, clinical studies, medical/scientific writing, and regulatory submissions for medical devices. She is Cook’s Global Leader for Clinical Affairs which is responsible for the design, oversight, and management of pre-market and post-market clinical projects. She also collaborates with experts on Good Clinical Practice (GCP) including the international standard ISO 14155 (Clinical standard for conducting medical device studies)

Stephanie Flipo

Director Strategy, Veeva MedTech Europe

Veeva MedTech

Stéphanie Flipo is Director of Clinical Strategy, MedTech for Veeva Systems in Europe. With more than 15 years of experience in Clinical Operations on both CRO and industry side, as well as on drug and device trials, she has a deep understanding on the planning, set-up, conduct and oversight on clinical trials. Before joining Veeva, Stéphanie was a Clinical Research Manager at Sirtex Medical driving the European clinical trials activities.

On-Demand Webinar

Fill out the form below for instant access.